January 16, 2007
Chris Viehbacher has served as President, US Pharmaceuticals, GlaxoSmithKline since January 2003. Previously he had been President, Pharmaceuticals Europe, since January 2001.
Chris joined the company when it was Wellcome GmbH, Germany in 1988 as Chief Financial Accountant and was promoted to Finance Director in 1989. From 1993 to 1995, he served as President and Chief Executive Officer of Burroughs Wellcome Inc., Canada. He joined Glaxo Wellcome France in 1995 as Vice President, Strategy and Integration, following a period based in London as a member of the coordination team during the Glaxo Wellcome integration. In 1996, he became General Manager of Glaxo Wellcome France and the following year was promoted to Chairman and Managing Director.
In January 1999, he took on the additional role of Director, Continental Europe (President Directeur General) of Glaxo Wellcome France. He was then named Regional Director, Europe for Glaxo Wellcome in 2000 and served as a member of the Glaxo Wellcome Executive Committee.
In 2003, the French Republic recognized Chris with its prestigious Légion d'Honneur award for his contributions to business and healthcare.
Before joining Glaxo Wellcome, Chris worked with Price Waterhouse in Germany and Canada. He graduated from Queen's University, Ontario, with a degree in Commerce and completed his training in Canada as a Chartered Accountant.
Chris resides in Raleigh, North Carolina, with his wife Alison and their three children. He is a board member of the CEO Roundtable on Cancer, North Carolina Citizens for Business & Industry, CEO Advisory Council, North Carolina GlaxoSmithKline Foundation and Triangle United Way.
He holds a dual German and Canadian citizenship.
Previous Speakers:
|



Speaker: President, US Pharmaceuticals, GlaxoSmithKline Chris Viehbacher
"My objective this afternoon isn't to scare everyone."

"The difference between the flu and a cold."

"Should you cover your mouth if you cough?"

"Pandemics come in cycles."

"Seasonal flu is nothing to sneeze at."

"How will we know when a pandemic is here?"

"What about a vaccine?"

"Planning for a pandemic."

"What GSK needs to think about in terms of handling the pandemic."

"Do we really need to be worried?"

"What can you do?"

of Chris Viehbacher's speech.
|